Yinsheng S. Chen

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Plasma metabolites link healthy lifestyle to the risk of epilepsy in the UK Biobank.

Plasma metabolites link healthy lifestyle to the risk of epilepsy in the UK Biobank.

Journal: Scientific reports

Published: January 28, 2026

Genomic landscape and immunological profile of glioblastoma in East Asian patients.

Genomic landscape and immunological profile of glioblastoma in East Asian patients.

Journal: Cell reports. Medicine

Published: May 24, 2024

Management and survival trends for diffuse gliomas diagnosed at a single neurooncology center in China during 2000 to 2020.

Management and survival trends for diffuse gliomas diagnosed at a single neurooncology center in China during 2000 to 2020.

Journal: Scientific reports

Published: April 24, 2024

A bibliometric analysis of research trends and hotspots of pilocytic astrocytoma from 2004 to 2023.

A bibliometric analysis of research trends and hotspots of pilocytic astrocytoma from 2004 to 2023.

Journal: Neurosurgical review

Published: February 05, 2024

A Study on Prognosis of Diffuse Glioma Based on Clinical Factors and Magnetic Resonance Imaging Radiomics.

A Study on Prognosis of Diffuse Glioma Based on Clinical Factors and Magnetic Resonance Imaging Radiomics.

Journal: World neurosurgery

Published: November 07, 2023

Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.

Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 29, 2023

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.

Journal: JAMA network open

Published: January 27, 2023

The Association Between Socioeconomic Factors at Diagnosis and Survival in Medulloblastoma: A Propensity Score-Matched Analysis and Population-Based Study.

The Association Between Socioeconomic Factors at Diagnosis and Survival in Medulloblastoma: A Propensity Score-Matched Analysis and Population-Based Study.

Journal: Journal of racial and ethnic health disparities

Published: December 11, 2022

Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study.

Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study.

Journal: Molecular oncology

Published: October 28, 2022

Correction to: Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.

Correction to: Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.

Journal: European radiology

Published: May 19, 2022

Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.

Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.

Journal: European radiology

Published: November 29, 2021

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis.

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis.

Journal: Frontiers in pharmacology

Published: October 29, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026